Resource

 

 

 

 

 

 

 

 

 

 

 

M&A: Acquiror's Counsel

Niederer Kraft & Frey advises NJJ Capital SAS in its acquisition of Orange Communications SA, Switzerland

30 Dec 2014

Apax and NJJ Capital SAS, Xavier Niel's private holding company, have agreed to sell mobile telecom operator Orange Communications SA for a total transaction value of CHF 2.8 billion (EUR 2.3 billion). The transaction is subject to customary regulatory approval and expected to complete by the end of Q1 2015.

Niederer Kraft & Frey has acted as Lead M&A and Regulatory Legal Counsel to NJJ Capital for the transaction, and as Swiss legal counsel to NJJ Capital for tax and financing related matters.

DLA Piper represents Cushman & Wakefield in its acquisition of Massey Knakel

24 Dec 2014

DLA Piper advised Cushman & Wakefield, a global leader of commercial real estate services, in its acquisition of Massey Knakel Realty Services, New York’s number one investment sales firm by transaction volume for more than a decade.

The transaction will further strengthen Cushman & Wakefield’s capital markets presence in the tri-state region. It is also representative of an ongoing consolidation trend in the commercial brokerage industry.

Completion of Public Tender Offer by KUKA Aktiengesellschaft for Swisslog Holding AG

24 Dec 2014

In the cash public tender offer by KUKA Aktiengesellschaft, Augsburg, Germany, for the publicly held shares of Swisslog Holding AG, listed on SIX Swiss Exchange and headquartered in Buchs/Aarau, Switzerland, a total of 230'678'047 Swisslog shares were tendered into the offer, corresponding to 91.80% of all shares issued by Swisslog as of 29 September 2014. KUKA consummated the offer on 15 December 2014.

Wiersholm has advised Nordic Capital in connection with agreement to acquire Vizrt

24 Dec 2014

A company controlled by Nordic Capital Fund VIII ("Nordic Capital") has entered into a merger agreement with Vizrt Ltd. pursuant to which Nordic Capital will pay a cash consideration of NOK 37 per Vizrt share for 100% of the issued share capital of the company.

The agreement values the share capital of Vizrt at approximately NOK 2.5 billion. Wiersholm has advised Nordic Capital in the process.

Wiersholm's team was headed by Kai Thøgersen and Simen Mejlaender.

DLA Piper and Ropes & Gray jointly advise consortium on acquisition of Avant Homes Group

23 Dec 2014

DLA Piper and Ropes & Gray have jointly advised a consortium of funds comprising Alchemy Special Opportunities, Angelo, Gordon & Co and Avenue Capital, in relation to its purchase of Avant Homes Group.

The DLA Piper team's role encompassed a full due diligence review of the target group, advice on the auction process and subsequent completion of the acquisition.

The DLA Piper team was led by Restructuring group partner Jonathan Richards with support from associate Antonio Del Riccio.

Zhong Lun Advises Pengrui Investment Group on its investment in KOLO Medical Ltd.

23 Dec 2014

Shenzhen Pengrui Investment Group Co., Ltd. has just completed its purchase of the Series A-1 Preferred Shares of Kolo Medical Ltd., a leading company in ultrasound technology, with operations in Silicon Valley, Hong Kong and Mainland China. Zhong Lun acted as legal counsel to Pengrui, with a team comprised of Wendy Wu, T.K. Chang (New York Office) and Roger Li.

Roschier represented Orkla in the acquisition of Condite

23 Dec 2014

Roschier represented Orkla, a leading supplier of branded consumer goods in the Nordic and Baltic region, in its acquisition of 67% of the shares in Condite Oy. The strategically important acquisition is carried out through Orkla’s wholly-owned subsidiary KåKå AB and will further strengthen Orkla’s leading position in the Nordic region in sales and distribution to the bakery and café market.

Austria: Schoenherr advises Roche on its acquisition of biotech firm Dutalys

23 Dec 2014

Schoenherr served as lead counsel to life sciences group Roche on its acquisition of Dutalys GmbH, a privately held biotechnology company based in Vienna, Austria. Dutalys specializes in the discovery and development of fully human, bi-specific antibodies based on their proprietary DutaMabs technology. The bi-specific antibodies developed with this platform are designed to provide novel, best-in-class molecules for several therapeutic areas.

White & Case Advises IMA on Acquisition of Majority Stake in OYSTAR Group

22 Dec 2014

White & Case LLP is advising I.M.A. Industria Macchine Automatiche S.p.A. (IMA) on its proposed acquisition for approximately €65 million of an 80 percent stake in OYSTAR Group from leading independent German private equity group Odewald.

IMA designs and manufactures automatic processing and packaging machines for the pharmaceutical, cosmetics, tea, coffee and food industries. The group has more than 3,700 employees worldwide and is active in around 80 countries.